Status of Import License (Form 10) of Human Vaccines, Recombinant Products and Veterinary Vaccine issued from 01/01/2015 to 27/02/2015
|
|
- Grant Berry
- 6 years ago
- Views:
Transcription
1 Status of Import License (Form 10) of Human Vaccines, Recombinant Products and Veterinary Vaccine issued from 01/01/2015 to 27/02/2015 S. No. Firm Name of Formulation Import LicenseNo. & Validity HUMAN VACCINES 1. M/s.GlaxoSmithKline Pharmaceuticals Ltd., Dr. Annie Besant Road, Mumbai, India 2. M/s.GlaxoSmithKline Pharmaceuticals Ltd., Dr. Annie Besant Road, Mumbai, India 3. M/s Sanofi Pasteur India Private Limited, 54/A Sir MathuradasVasanji Road, Andheri East, Mumbai , India 1. Diphtheria, Tetanus and Pertussis (Acellular Component) Vaccine (Adsorbed) Ph. Eur. Composition: Each 0.5ml vaccine contains 2 IU (2.5 Lf) of diphtheria toxoid, 20 IU (5 Lf) of tetanus toxoid, 8µg of Pertussis toxoid (PT), 8µg of Filamentous Haemagglutinin (FHA) and 2.5µg of Pertactin (PRN) adsorbed on aluminium hydroxide (Total 0.3 mg Al3+) and aluminum phosphate (Total 0.2 mg Al3+) 2. Diphtheria, Tetanus and Pertussis (Acellular Component) Vaccine (Adsorbed) Ph. Eur. Composition: Each 0.5ml vaccine contains Not less than 30 IU of diphtheria toxoid (DT), Not less than 40 IU of tetanus toxoid (TT), 25µg of de-toxified Pertussis toxin (PT), 25µg of formalin-treated filamentous haemagglutinin (FHA) and 8µg of formalin-treated Pertactin adsorbed on 0.5 mg of aluminium as aluminium hydroxide 1. Live Attenuated Measles, Mumps, Rubella and Varicella Vaccine 1. Haemophilus type B Conjugate Vaccine. I.P. vial with Diluent 2. Typhoid Polysaccharide Vaccine I.P. 3. Inactivated Hepatitis A Vaccine, Adsorbed. I.P. Hepatitis A virus, GBM strain (Inactivated) 80 Page 1 of 12 SV-15-3 SV-15-3 valid up to 31/12/2017 SV-5-42
2 4. M/s. GlaxoSmithKline Pharmaceuticals Ltd., Patiala Road, Nabha (Punjab) 14720, India antigen units 4. Inactivated Hepatitis A Vaccine (Adsorbed) I.P. Hepatitis A virus, GBM strain (Inactivated) 160 antigen units 5. Poliomyelitis Vaccine I.P., Oral (Trivalent) 6. Pneumococcal Polysaccharide Vaccine. I.P. 7. Yellow Fever Vaccine (Live). I.P. 8. Inactivated Influenza Vaccine (Split Virion, inactivated) I.P. (0.5 ml dose) 9. Inactivated Influenza Vaccine (Split Virion, Inactivated.) I.P. (0.25 ml dose) 10. Rabies vaccine, Human IP. 11. Inactivated Poliomyelitis Vaccine 12. Combined vaccine DtacP-IPV-PRP-T Injection 13. Yellow Fever Vaccine (Live) multidose presentation (ten dose vial) along with diluent. 1. Bulk unlabelled vials or PFS of Pneumococcal Polysaccharide Conjugate Vaccine (adsorbed) Ph. Eur. 2. Bulk unlabelled PFS of Diphtheria, Tetanus and Pertusis (Acellular Component) vaccine (adsorbed) Ph. Eur. 3. Bulk unlabelled vials of Hepatitis B Virus Vaccine IP (genetically engineered) 4. Bulk unlabelled vials or PFS of Inactivated Hepatitis A Vaccine (Adsorbed) IP 5. Bulk unlabelled vials of Haemophilus Type b Conjugate Vaccine IP and bulk vial or PFS or Ampoule of diluent 6. Bulk unlabelled vials or PFS of Meningococcal Polysaccharide Vaccine IP and bulk sealed vial or PFS or Ampoule of diluent 7. Bulk unlabelled vials of Measles, Mumps and Rubella Vaccine (live) and bulk sealed vial or PFS or Ampoule of diluent Page 2 of 12 SV Valid up to 11/12/2016
3 5. M/s G. C. ChemiePharmie Ltd., 5/C, Shree Laxmi Ind. Estate, New Link Road, Andheri (West), Mumbai , India 6. M/s Sanofi Pasteur India Private Limited, 54/A Sir MathuradasVasanji Road, Andheri East, Mumbai , India 7. M/s Serum Institute of India Ltd., 212/2, Hadapsar, Pune, India 8. M/s.GlaxoSmithKline Pharmaceuticals Ltd., Dr. Annie Besant Road, Mumbai, India 8. Bulk unlabelled PFS of Hepatitis A (Inactivated) and Hepatitis B (r-dna) Vaccine (Adsorbed) IP 9. Bulk unlabelled PFS of Typhoid Polysaccharide Vaccine IP 10. Bulk unlabelled vials of Varicella Vaccine, Live IP and and bulk sealed vial or PFS or Ampoule of diluent 11. Bulk unlabelled PFS of Diphtheria, Tetanus and Pertussis (Acellular Component) Vaccine (Adsorbed) Ph. Eur. 12. Bulk unlabelled vials of Rotavirus vaccine, (Live Attenuated, oral) IP and bulk sealed PFS of diluent. 13. Bulk unlabelled vials or PFS of Human Papillomavirus vaccine Ph. Eur ml Inactivated Influenza Vaccine (Split Virion) I.P., Suspension for injection in prefilled syringes ml Inactivated Influenza Vaccine (Split Virion) I.P., Suspension for injection in prefilled syringes 1. Combination Vaccine of Diphtheria Toxoid and Acellular Pertussis suspension for suspension for single use(0.5ml) 2. Combination vaccine of Diphtheria Toxoid, Tetanus Toxoid And Acellular Pertussis suspension for single use (0.5ml) 1. Bulk Inactivated Trivalent Poliomyelitis Vaccine containing concentrated amounts of inactivated polio virus. 1. Hepatitis B Virus Vaccine IP 2. Inactivated Hepatitis A Vaccine (Adsorbed) IP 3. Pneumococcal polysaccharide and Non-Typeable Haemophilus influenza(nthi) protein D conjugate vaccine, adsorbed 4. Hepatitis A (Inactivated) and Hepatitis B (r-dna) Vaccine (Adsorbed) IP 5. Varicella vaccine, Live IP SV valid up to 09/08/2017 SV valid up to 31/12/2017 SV valid up to: 31/01/2018 SV Page 3 of 12
4 9. M/s. GlaxoSmithKline Pharmaceuticals Ltd., Patiala Road, Nabha (Punjab), India 10. M/s. GlaxoSmithKline Pharmaceuticals Ltd., Patiala Road, Nabha (Punjab), India 11. M/s. GlaxoSmithKline Pharmaceuticals Ltd., Patiala Road, Nabha (Punjab) 14720, India 12. M/s. GlaxoSmithKline Pharmaceuticals Ltd., Patiala Road, Nabha (Punjab), India 13. M/s Abbott India Limited, Corporate Park, Sion-Trombay Road, Chembur, Mumbai, India 14. M/s. Shantha Biotechnics Ltd. Survey No. 274, Athvelli village, 1. Diphtheria, Tetanus and Pertussis (Acellular Component) vaccine (Adsorbed)Ph.Eur Composition: Each 0.5ml vaccine contains Not less than 30 IU of diphtheria toxoid (DT), Not less than 40 IU of tetanus toxoid (TT), 25 µg of de-toxified Pertussis toxin (PT), 25 µg of formalin-treated filamentous haemagglutinin& 8 µg of formalin-treated Pertactin adsorbed on 0.5 mg of aluminium as aluminium hydroxide 1. Diphtheria, Tetanus and Pertussis (Acellular Component) vaccine (Adsorbed)Ph.Eur Composition: Each 0.5ml vaccine contains 2 IU (2.5 Lf) of diphtheria toxoid, 20 IU (5 Lf) of tetanus toxoid, 8 µg of Pertussis toxoid (PT), 8µg of Filamentous Haemagglutinin (FHA) and 2.5µg of Pertactin (PRN) adsorbed on aluminium hydroxide (Total 0.3 mg Al3+) and aluminum phosphate (Total 0.2 mg Al3+) 1. Hepatitis B Virus Vaccine IP 2. Inactivated Hepatitis A Vaccine (Adsorbed) IP 3. Hepatitis A (Inactivated) and Hepatitis B (r-dna) Vaccine (adsorbed) IP 4. Varicella Vaccine, Live IP 1. Haemophilus Type b conjugate vaccine IP 2. Measeles Mumps Rubella Vaccine(Live) IP 3. Typhoid Polysaccharide vaccine IP 4. Meningococcal Polysaccharide vaccine IP ml Inactivated Influenza vaccine (surface antigen), I.P., suspension for Injection in prefilled syringes 1. Inactivated Vero Trivalent Polio Vaccine Bulk (concentrated trivalent) Page 4 of 12 SV SV SV Sv SVH valid up to: 30/04/2018 SVH valid up to: 31/07/2017
5 Medchal Mandal, Rangareddy Dist.Andhra Pradesh, India. 15. M/s Merck Specialities Pvt. Ltd, Plot No. D-116, MIDC, Bldg No. 2, 1 st Floor, Thane Belapure Road, Shir Vane, Navi Mumbai , Maharashtra, India 16. M/s. Sandor Medicaids Pvt Ltd, /5, Road No.3, Banjara Hills, Hyderabad , India. 17. M/s Roche Products (India) Pvt. Ltd., Plot No. 13-A, Paper Box (East),Mumbai , India 18. M/s Roche Products (India) Pvt. Ltd., Plot No. 13-A, Paper Box (East),Mumbai , India 19. M/s. Boehringer Ingelheim India Pvt. Ltd., Bld No.D-5, Gala no:1 to 3, Shree Arihant Compound, Ground Floor, RetiBunder Road, Kalher, Bhiwandi, Tal: Bhiwandi 15 (Thane Zone 5) Pin: , Maharashtra, India RECOMBINANT PRODUCTS 1. Follitropin alpha (r-dna human Follicle Stimulating Hormone) solution for injection in pre-filled pen 2. Chorionic gonadotropin alpha (r-dna Human Chorionic Gonadotropin Hormone) solution for injection 3. r-dna Human Somatotropin Hormone Injection 4. r-hu-lutenising Hormone powder for solution for injection 5. Follitropin alpha (r-dna human Follicle Stimulating Hormone) in lyophilized powder in vials 1. Agalsidase beta powder for concenterate for solution for infusion FFR valid up to: 21/04/2018 FF valid up to: 30/09/ Trastuzumab Emtansine for injection (r-dna origin) FFR valid up to: 02/02/ Trastuzumab Powder for Concentrate for solution for Infusion in vials (440mg) 2. Bacteriostatic water for Injection (solvent for Trastuzumab for injection 20 ml Vial) 1. Alteplase for injection(ph.eur) (rt-pa- Recombinant Human Tissue Type Plasminogen Activator Inj. 20mg & 50 mg vials with Sterilised water for injection (Ph.Eur) 20ml and 50ml. 2. Tenecteplase (TNK-tPA) Injection Intravenous bolus Injection Each vial contains: Tenecteplase-40 mg: 8000 Units with Sterilised water for injection (Ph.Eur) 8 ml Tenecteplase-50 mg: Units with Sterilised water for FFR valid up to: 08/01/2018 FF-88-6 valid up to: 28/02/2018 Page 5 of 12
6 20. M/s Fulford (India) Limited, Gala No. 1D&2, Bldg. No. B-3, City Link Warehouses Complex, Mumbai Nashik Highway Vadapa, Bhiwandi Dist. Thane , Maharashtra, India 21. M/s. Pfizer Ltd, The Capital-A Wing, 1802, 18 th Floor, Plt No. C- 70, G block, Bandra (East), Mumbai , India 22. M/s. Merck Specialities Pvt Ltd., Shiv Sagar Estate A Dr. Annie Besant Road, Worli, Mumbai. 23. M/s. Eli Lilly & Company (India) Pvt Ltd. Plot No.92, Sector 32, Gurgaon , Haryana, India. 24. M/s. Roche Products (India) Pvt. 25. M/s. Eli Lilly & Company (India) Pvt Ltd., Plot No.92, Sector-32, Gurgaon, , Haryana, India. injection (Ph.Eur) 10ml 1. Pegylated Interferon alfa-2b 50mcg, 80mcg, 100mcg, 120mcg & 150mcg Powder for Injection in vials. 2. Interferon alfa-2b 18MIU, 30MIU & 60MIU Injection in Multidose Pen. 1. Etanercept Injection 25 mg /Pre Filled Syringe (Solution, 1ml). 2. Etanercept Solution for Injection 50 mg in Pre Filled Pen. FF FF Cetuximab Injection. FF valid up to: 31/03/ Abciximab Solution for injection 10mg/5ml vial. FFR valid up to: 31/03/ Trastuzumab Powder for Concentrate for solution for Infusion in vials (150mg). 2. Bevacizumab Concentrate for Solution for Infusion in vials (100mg/4ml and 400mg/16ml). 3. Bacteriostatic Water for Injection 20ml vial (Solvent for Trastuzumab). 1. Insulin Human (r-dna origin -100 IU/ml 3ml Cartridges ofhuminsulin R (Regular) (Insulin Human Injection). 2. Insulin Human (r-dna origin -100 IU/ml 3ml Cartridges of Huminsulin N (NPH) (Isophane Insulin Human Suspension). 3. Insulin Human (r-dna origin -100 IU/ml 3ml Cartridges of Huminsulin 30/70 (30% Neutral Insulin Solution & 70% FF-1-33 FF valid up to 31/12/2017 Page 6 of 12
7 26. M/s. NovoNordisk India Pvt Ltd., Plot No. 32, 47-50, EPIP Area, Whitefield, Bangalore , India. Isophane Suspension Human) % Insulin Lispro& 75% Insulin Lispro Protamine Suspension (r-dna origin) Mix IU/ml (3ml Cartridges) 5. 50% Insulin Lispro& 50% Insulin Lispro Protamine Suspension (r-dna origin) Mix IU/ml ( 3 ml Cartridges) 6. Somatropin- 18 IU (6mg)/36 IU (12 mg), (Somatropin for injection (r-dna origin)- Cartridges with Sterile Diluent syringe with a needle for injection) 7. Teriparatide injection (r-dna origin (Teriparatide), 600 mcg/2.4 ml. 1. Soluble Insulin Injection I.P.( Insulin Human Biosynthetic, r- DNA origin ) 2. Isophane Insulin Injection I.P. (Insulin Human Biosynthetic, r- DNA origin ) 3. Biphasic Isophane Insulin Injection I.P.(Insulin Human Biosynthetic, r-dna origin) 4. Pre-Mixed Human Insulin Analogue Injection (Biosynthetic, Monocomponent r-dna origin) 5. Human Growth Hormone Injection (Somatropin) (Biosynthetic, r-dna origin) 6. Eptacog Alfa-Activated, human Coagulation VII Activated (Biosynthetic, r-dna origin) 7. Human Insulin Analogue Injection-Insulin Detemir (Biosynthetic, Monocomponent r-dna origin) 8. Liraglutide, Glucagon-Like Peptide-1 analogue 9. Insulin degludec (r-dna origin) solution for subcutaneous injection. 10. Soluble Insulin Injection I.P. (Human Insulin, Biosynthetic, Page 7 of 12 FF valid up to 31/12/2017
8 27. M/s. Roche Products (India) Pvt 28. M/s. Roche Products (India) Pvt (East), Mumbai, India. 29. M/s.GlaxoSmithKline Pharmaceuticals Ltd., Dr. Annie Besant Road, Mumbai, India 30. M/s. Eli Lilly & Company (India) Pvt Ltd.,Plot No.92, Sector 32, Gurgaon, , Haryana, India 31. M/s. Novartis India Ltd., Bld No.27, Gala No.1-4 Bld No. 28, Arihant Compound, PurnaBhiwandi (Thane-Zone5), India. Monocomponent, r-dna origin) 40IU/ml in 10ml vials. 11. Isophane Insulin Injection I.P. (Human Insulin, Biosynthetic, Monocomponent, r-dna origin) 40IU/ml in 10ml vials. 12. Biphasic Isophane Insulin Injection I.P. (Human Insulin, Biosynthetic, Monocomponent, r-dna origin) (30% Soluble + 70% Isophane Insulin) 40IU/ml in 10ml vials. 13. Insulin degludec/ Insulin Aspart (r-dna origin) solution for Subcutaneous injection. 1. Trastuzumab Powder for concentrate for solution for infusion in vials(440mg) 2. Rituximab Concentrate for solution for infusion in Vials (500mg/50ml and 100mg/10ml) 1. Bevacizumab Concentrate for Solution for Infusion in vials (100mg/4ml and 400mg/16ml). 1. Ofatumumab Concentrate for solution for Infusion (r-dna Origin) 1. Insulin Lispro (r-dna origin) 100IU/ml Solution for injection, 3ml cartridge % Insulin Lispro and 75% Insulin Lispro Protamine (r- DNA origin) Suspenion for injection 100IU/ml, 3ml cartridges. 1. Basiliximab Injection/ I.V. infusion 2. Omalizumab Injection FF FF FFR valid up to 31/12/2017 FFR Valid up to 31/01/2018 FF-52-7 Page 8 of 12
9 32. M/s. Reliance Life Science Pvt Ltd. Of DhirubhaiAmbani Life Science Centre (DALC), Thane- Belapur Road, Mumbai, India. 33. M/s. Roche Products (India) Pvt. 34. M/s. Roche Products (India) Pvt. 35. M/s. Roche Products (India) Pvt. 36. M/s. Roche Products (India) Pvt. 37. M/s. Roche Products (India) Pvt. 38. M/s. Roche Products (India) Pvt. 39. M/s. Roche Products (India) Pvt. 1. Recombinant Human Erythropoetin Alfa Concentrate Solution (Bulk) 1. Methoxy Polyethylene glycol-epoetin beta solution for Injection in PFS 30µg, 40µg, 60µg, 120µg in 0.3ml Prefilled Syringes and 360µg in 0.6 ml Prefilled Syringes. 1. Methoxy Polyethylene glycol-epoetin beta Solution for Injection in 50µg, 75µg, 100µg, 150µg, 200µg, 250µg in 0.3ml PFS. 1. Rituximab Concentration for solution for Infusion in vial 100mg/10ml & 500mg/50ml. 1. Trastuzumab Powder for Concentrate for Solution for Infusion in 150 mg vials. 2. Peginterferon alfa-2a solution for Injection in 180mcg/0.5ml & 135mcg/0.5ml PFS. 1. Epoetin beta Solution for Injection in 2000IU, 3000IU, 4000IU, 5000IU, 10,000IU and 30,000IU Pre-Filled Syringes. 1. Rituximab Concentrate for Solution for Infusion in Vials (500mg/50ml and 100mg/10ml). 2. Peginterferon alfa-2a for solution for Injection in 180mcg/0.5ml & 135 mcg/0.5 ml Pre filled Syringes 1. Bevacizumab Concentrate for Solution for Infusion 100mg/4ml & 400mg/16ml. Page 9 of 12 FFR Valid up to FF-3-46 valid up to 31/12/2017 FF-3-12 FF-3-85 FF-3-31 FF FF FF-3-70
10 40. M/s Intervet India Pvt. Ltd., S.No. 136, Build.-3,3A,+4C ColdRoom Ware House Brihanagar, Pune- Nagar Road Wagholi, Pune, Tal: Wagholi (Pune-Zone1) Maharashtra, India VETERINARY VACCINES 1. Combined Infectious Bursal Disease & Newcastle disease Vaccine, Inactivated, Water in oil emulsion. 2. Ranikhet Disease Vaccine, Inactivated, I.P. 3. Combined Avian Infectious Bronchitis Disease & Newcastle disease Vaccine, Inactivated, Water in oil emulsion. 4. Combined Avian Encephalomyelitis and Fowl Pox Vaccine, Live, Freeze dried. 5. Mycoplasma Gallisepticum Vaccine, Live, Freeze dried. 6. Avian Infectious Bronchitis Vaccine, Live, I.P. 7. Reo Virus Vaccine, Inactivated, I.P. 8. Infectious Bursal Disease Vaccine, Live, I.P. 9. Mycoplasma Gallisepticum Vaccine, Inactivated. 10. Ranikhet Disease Vaccine, Inactivated, I.P. 11. Combined Avian Infectious Bronchitis Disease, Infectious Bursal Disease, Newcastle Disease and Reo virus Vaccine, Inactivated, Water in oil emulsion. 12. Rabies vaccine (cell cultured, Inactivated) for veterinary use. 13. Infectious Coryza Vaccine, Inactivated, I.P. 14. Combined Canine Distemper, Canine Adenovirus, Canine Parvovirus & canine Parainfluenza Vaccine, Live, Freeze dried. 15. Combined Canine Distemper & Canine Parvovirus Vaccine, Live, Freeze dried. 16. Combined Avian Infectious Bronchitis Disease, Infectious Bursal Disease & Newcastle Disease Vaccine, Inactivated, Water in oil emulsion. 17. Combined Avian Infectious Bronchitis &Ranikhet disease SV Page 10 of 12
11 41. M/s Zoetis India Limited, RetiBunder Road, Kalher, Tah. Bhiwandi, Dist Thane, India 42. M/s Panav Bio-Tech, Shop No. 131, 1 st Floor, Vardhman Big V Plaza,Plot No. 12, C-Centre, Road No. 44, Rani Bagh, Pitampura, Delhi , India 43. M/s Virbac Animal Health India Pvt. Ltd., Western Edge-I, Vaccine, Inactivated, Water in oil emulsion. 18. Salmonella enteritidis& Salmonella typhimurium Vaccine, Inactivated, I.P. 19. Avian colibacillosis Vaccine, Inactivated, Water in Oil Emulsion. 20. Combined Rabies & Canine Leptospirosis Vaccine, Inact. 21. Infectious Bursal Disease Vaccine, Live, I.P. 22. Ranikhet disease Vaccine, Live, I.P. 23. Ranikhet disease Vaccine, Live, I.P. 24. NOBILIS CORVAC is an inactivated trivalent poultry vaccine containing serotype A, B and C of Avibacteriumparagallinarum. 25. Live, Freeze-dried vaccine against Bordetellabronchiseptica and Canine parainfluenza virus (Nobivac KC). 26. Canine Leptospirosis Vaccine, Inactivated, I.P. 1. Mycoplasma Synoviae Vaccine, Live (Strain MS-H) SV valid up to: 18/02/ Vaccines against Canine Distemper, Parvovirus, Parainfluenza, Hepatitis, Adenovirus, Corona virus and 5 Leptospirosis. 2. Vaccine against Canine Distemper, Parvovirus, Parainfluenza, Hepatitis, Adenovirus, Corona virus and Leptospirosis. 3. Vaccine against Corona virus in Dogs. 4. Vaccines against Canine Distemper, Parvovirus, Parainfluenza, Adenovirus type 2 and Leptospirosis infections in dogs, 1ml vial along with 1 ml vial of diluent. 1. Rabies Veterinary Vaccine, Inactivated (Cell Culture), I.P. Ten dose SVV-2-03 valid up to: 31/03/2018 SV valid up to: 14/03/2017 Page 11 of 12
12 Western Express Highway, Magathane, Borivili, Mumbai. Page 12 of 12
Status of Registration Certificate (Form 41) of Human Vaccines, Recombinant Products and Veterinary Vaccine issued from 01/01/2015 to 27/02/2015
Status of Registration Certificate (Form 41) of Human Vaccines, Recombinant Products and Veterinary Vaccine issued from 01/01/2015 to 27/02/2015 S. No. Firm Name of Formulation Registration Certificate
More informationStatus of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015 S. No. Firm Name of Formulation Registration Certificate No. & Validity 1. M/s. Nirlac Chemicals,14 th
More informationStatus of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016 RECOMBINANT PRODUCTS S. No. Firm Name of Formulation Import License No. &
More informationStatus of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016
1. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India 2. M/s Eli Lilly and Co (I) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1 st Fl, Arihant Comm. Complex,
More informationStatus of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/01/2017 to 31/12/2017
1. M/s Zuventus Healthcare Limited Office No. 5119,5 th Floor, Oberoi Garden Estate, Chandivali, Andheri (East) Mumbai, Tal: Sakinaka (Mumbai -Zone 4) Pin: 400072 2. M/s. Shantha Biotechnics Limited, Survey
More informationPREPARATION STANDARD MATERIAL HELD AT CODE WHO/BS DOCUMENT. 1st Reference Reagent, 2009
WHO International Biological Reference Preparations Held and Distributed by the WHO International Laboratories for Biological Standards Acellular pertussis vaccine for potency assay by modified mouse challenge
More informationVACCINE MANAGEMENT. Recommendations for Handling and Storage of Selected Biologicals. January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES
VACCINE MANAGEMENT Recommendations for Handling and Storage of Selected Biologicals January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES DTaP: Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis Vaccine
More informationApproval / Acknowledgement Letter Ref No. / Diary no F.No.12-48/GSK/PAC- Synflorix/15-BD 25-Mar-15 2 GlaxoSmithKline Pharmaceuticals Limited.
1 GlaxoSmithKline Deletion of a n-significant in-process test limit during the purification process of the tetanus / diphtheria toxoids used in the manufacture of GSK's PCV vaccine [brand name: Synflorix]
More informationWHO International Biological Reference Preparations Held and distributed by the WHO International Laboratories for Biological Standards
WHO International Biological Preparations Anthrax spore vaccine. Lyophilized spore suspension of Bacillus anthracis strain 34 F2. 1 IU / ampoule. Anti-brucella abortus serum, bovine. Lyophilized. 1,000
More informationThe List is only for reference purpose and may not be used for License or other Statutory Clearance
List of approved veterinary drugs and devices till 17.03.2015 A-List of Veterinary drugs Approved Sr. No. Drug Name Date of issue Nil Nil Nil B-List of Veterinary drugs registered-(finish Formulation)
More informationAnnex 1. WHO Recommendations, Guidelines and other documents related to the manufacture and quality control of biological substances used in medicine
WHO related to the manufacture and quality control of biological substances used in medicine WHO are intended to provide guidance to those responsible for the production of biological substances as well
More informationBharat Biotech. Hyderabad. Type of PAC (Supplement and Notifiable / Permission Granted by CDSCO) S. No Product
Bharat Biotech Hyderabad S. No Product Type of PAC (Supplement and / Permission Granted by CDSCO) PAC Details Date of NOC in manufacturing process of Oral Polio F.No. 12-63/BHARAT/(PACOPV)/13-BD 30.08.2013
More informationCentral Inspection Plan Using Risk Based Approach Of Vaccine Manufacturing Units for 2017
, follow-up, failure A NORTH ZONE 1 M/s Biomed Pvt. Ltd, C-96, Site I, Bulandshahar Road, Ind. Area, Ghaziabad. 1. Oral Polio Vaccine IP, 2. Vi Typhoid Vaccine (Bio Typh TM ) IP, 3. Haemophilus Type-B
More informationVaccines and other immunological antimicrobial therapy 1
Vaccines and other immunological antimicrobial therapy 1 Vaccines Vaccine: a biological preparation that provides active acquired immunity to a particular disease. Vaccine typically contains an agent that
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory HIBERIX
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory HIBERIX Haemophilus type b conjugated vaccine IP 1. NAME OF THE MEDICINAL PRODUCT Haemophilus type b conjugated vaccine
More informationModern Drug House.
+91-8048941768 Modern Drug House https://www.moderndrughouse.in/ We are one of the leading suppliers and traders of a wide range of Vaccine and Pharmaceutical Products. Owing to its effectiveness, purity
More informationCHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES
CHAPTER ONE: EXECUTIVE SUMMARY The Global Vaccine Industry o Scope and Methodology o Overview o Pediatric Preventative Vaccines o The Market o Adult Preventative Vaccines o The Market o Total Market o
More informationM I C R O B I O L O G Y
ninth edition TORTORA FUNKE CASE M I C R O B I O L O G Y a n i n t r o d u c t i o n 18 Practical Applications of Immunology PowerPoint Lecture Slide Presentation prepared by Christine L. Case Vaccine
More informationVaccination-Strategies
Vaccination-Strategies Active immunity produced by vaccine Immunity and immunologic memory similar to natural infection but without risk of disease. General Rule: The more similar a vaccine is to the disease-causing
More informationVaccinology 101 for Fellows
Vaccinology 101 for Fellows Meg Fisher, MD Medical Director, The Children s Hospital Monmouth Medical Center An affiliate of the Saint Barnabas Health Care System Long Branch, NJ Disclosures I have no
More informationDiphtheria-Tetanus-Acellular Pertussis-Polio- Haemophilus influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib)
Diphtheria-Tetanus-Acellular Pertussis-Polio- Haemophilus influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib) Section 7: Biological Product Information Standard #: 07.211 Created
More informationHealthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.
Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy
More informationBabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury-free We use aluminium-free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
More informationVACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
VACCINATION DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. It is used to induce the
More informationCPT 2016 Code Changes
CPT 2016 Code Changes Code Changes - Medicine New CPT 2016 New Codes Code Description 69209 Removal impacted cerumen using irrigation/lavage, unilateral 90620 Meningococcal recombinant protein and outer
More informationBabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury-free We use aluminium-free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
More informationPentabio Vaccine (DTP-HB-Hib)
SUMMARY OF PRODUCT CHARACTERISTICS Product Name Pharmaceutical Form Strength Presentation : Pentabio : Suspension for injection : 1, 5 and 10 doses : Box of 10 vials @ 0.5 ml Box of 10 vials @ 2.5 ml Box
More informationINFANRIX-IPV Product Information 1(13) INFANRIX IPV
INFANRIX-IPV Product Information 1(13) INFANRIX IPV NAME OF THE DRUG INFANRIX IPV vaccine is a combined diphtheria, tetanus, acellular pertussis (DTPa) and inactivated poliovirus vaccine. DESCRIPTION INFANRIX
More informationTable Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines
Table Of Contents Executive Summary THE GLOBAL VACCINES INDUSTRY Scope and Methodology Overview Pediatric Preventative Vaccines THE MARKET Adult Preventative Vaccines THE MARKET TOTAL MARKET ISSUES AND
More informationSUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT IP Solution for Oral Administration 2 ml single dose plastic dosing tube Brand Name: RotaTeq SUMMARY OF PRODUCT CHARACTERISTICS
More informationUse of Infanrix -IPV+Hib in the infant primary immunisation schedule
Use of Infanrix -IPV+Hib in the infant primary immunisation schedule An update for registered healthcare practitioners July 2014 Quality Education for a Healthier Scotland 1 Acknowledgments Many thanks
More informationTemperature Intelligence Solutions. Thermostability of Vaccines
Thermostability of Vaccines Why are all vaccines sensitive to heat and some to freezing? Why is thermostability of vaccine important? What can be done to improve the thermostability of vaccines? Goals
More informationCopyright regulations Warning
COMMONWEALTH OF AUSTRALIA Copyright regulations 1969 Warning This material has been reproduced and communicated to you by or on behalf of the University of Melbourne pursuant to part VB of the Copyright
More informationPractical Applications of Immunology. Chapter 18
Practical Applications of Immunology Chapter 18 I. Vaccines A. Definition A suspension of organisms or fractions of organisms that is used to induce immunity (immunologic memory). The mechanism of memory
More informationBabyJabs Vaccines. All vaccines are mercury- free We use aluminium- free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury- free We use aluminium- free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
More informationDiphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV)
Diphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV) Section 7: Biological Product Information Standard #: 07.212 Created by: Province-wide Immunization Program Standards
More informationAdvisory Committee on Immunization Practices VACCINE ACRONYMS
Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table of standardized
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory INFANRIX Diphtheria Tetanus and Pertussis (Acellular Component) Vaccine (Adsorbed) Ph. Eur. 1. NAME OF THE MEDICINAL PRODUCT
More informationSanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines 1 Vaccines: the single most effective medical intervention 2 Vaccines save lives Millions of cases
More informationGene Vaccine Dr. Sina Soleimani
Gene Vaccine Dr. Sina Soleimani Human Viral Vaccines Quality Control Laboratory (HVVQC) Titles 1. A short Introduction of Vaccine History 2. First Lineage of Vaccines 3. Second Lineage of Vaccines 3. New
More informationSUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) I.P. Injectable, Suspension for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 0.5 ml contains:
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory INFANRIX HEXA Diphtheria, tetanus, pertussis (acellular component), hepatitis B (rdna), poliomyelitis (inactivated) and
More informationThe Scientific Relevance of the ATT Today and from a historical Perspective
www.pei.de The Scientific Relevance of the ATT Today and from a historical Perspective Dr. Klaus Cussler EPAA International Workshop Towards global harmonization of 3Rs in biologicals 15-16 September 2015
More informationStainless-steel vs Single-use: The Vaccines Perspective
Stainless-steel vs Single-use: The Vaccines Perspective CMO-Biomanufacturer Panel Tue 21 April, Noon-1:30pm, Exhibit Hall Daniel C.Vellom, PhD Sr. Director Global Technology Innovation 2015 INTERPHEX 1
More informationAdvisory Committee on Immunization Practices VACCINE ACRONYMS
May 1, 2015 Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table
More informationImmunizations for Children and Teens with Suppressed Immune Systems
Immunizations for Children and Teens with Suppressed Immune Systems Your child is starting treatment that will suppress the immune system. This will affect how your child s body responds to routine immunizations
More informationPrinciples of Vaccination
Immunology and Vaccine-Preventable Diseases Immunology is a complicated subject, and a detailed discussion of it is beyond the scope of this text. However, an understanding of the basic function of the
More informationPreventative Vaccines. Vaccines for Special Populations. Vaccinations for Adults: An Update. Vaccines Generally Available in the U.S.
Vaccinations for Adults: An Update Preventative Vaccines Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted Lisa G. Winston, MD University of California,
More informationInfanrix IPV. Copyright , MIMS Australia Page 1 of 6
Infanrix IPV MIMS Abbreviated Prescribing Information Diphtheria toxoid; pertussis vaccine; poliomyelitis vaccine; tetanus toxoid GlaxoSmithKline Australia Section: 10(a) Vaccines - Immunology Use in pregnancy:
More informationList of changes in Out-Patients Formulary
List of changes in Out-Patients Formulary Change in prescriber criteria Alpha Tocopheryl (Vitamin E) suspension 100mg/mL, tablets 50-150mg, tablets 670mg Atorvastatin tablets Bezafibrate tablets 400mg
More informationEUROPEAN MEDICINES AGENCY DECISION. of 31 March 2009
European Medicines Agency Doc. Ref. EMEA/160106/2009 P/64/2009 EUROPEAN MEDICINES AGENCY DECISION of 31 March 2009 on the acceptance of a modification of an agreed Paediatric Investigation Plan for Purified
More informationCoverage of Vaccines Medicaid and Child Health Plus Members
Coverage of Vaccines Medicaid and Child Health Plus Members For children between the ages 0-18, routine recommended vaccinations are covered through Vaccines for Children program [VFC]. Fidelis Care will
More informationBOOSTRIX -POLIO: Diphtheria-Tetanus- Acellular Pertussis-Polio Combined Vaccine Biological Page (dtap-ipv)
BOOSTRIX -POLIO: Diphtheria-Tetanus- Acellular Pertussis-Polio Combined Vaccine Biological Page (dtap-ipv) Section 7: Biological Product Information Standard #: 07.213 Created by: Province-wide Immunization
More informationNew Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines Antigens Vaccine Approved Age Daptacel Diphtheria, Tetanus, and acellular Pertussis (DTaP)
More information14: Immunological products and vaccines
File name: Immunological Products and s Formulary BNF Original Date of issue: 30/10/2005 Last Reviewed: 23/11/2012 Version:4 Page 1 of 6 14: Immunological products and vaccines 14.1 Active immunity Live
More informationBy:Reham Alahmadi NOV The production of antibodies and vaccination technology
By:Reham Alahmadi NOV 2018 The production of antibodies and vaccination technology Antibody Production The blood contains two types of white blood cell or leukocyte Phagocytes ingest bacteria by endocytosis
More informationDetailed cost of vaccination/ Immunization in India (Birth to 10 years of age)
Detailed cost of vaccination/ Immunization in India (Birth to 10 years of age) Glossary: IPV= Injectable Polio vaccine OPV= Oral polio vaccine (these are oral drops, which is also given in "Pulse Polio
More informationList of texts adopted at the November 2017 session of the European Pharmacopoeia Commission
Pharmeuropa Useful information February 2018 1 List of texts adopted at the November 2017 session of the European Pharmacopoeia Commission NEW TEXTS MONOGRAPHS Herbal drugs and herbal drug preparations
More informationArmed Services Blood Program Immunization List
Immunization List NOTICE: The Department of Defense (DoD) assumes no risk for the use of this information by non-dod personnel, blood programs, or individual medical institutions. The use of this information
More informationPREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.
An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Routine Immunizations Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 3 References... 7 Effective Date... 4/15/2018
More information1 Principles of Vaccination Immunology and Vaccine-Preventable Diseases... 1 Classification of Vaccines... 4 Selected References...
1 Principles of Vaccination Immunology and Vaccine-Preventable Diseases... 1 Classification of Vaccines... 4 Selected References... 7 2 General Recommendations on Immunization Timing and Spacing of Vaccines...
More information9/10/2018. Principles of Vaccination. Immunity. Antigen. September 2018
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Principles of Vaccination September 2018 Chapter 1 September 2018 Photographs and images included in
More informationSUMMARY OF PRODUCT CHARACTERISTICS. INFANRIX-IPV+Hib powder and suspension for suspension for injection
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT INFANRIX-IPV+Hib powder and suspension for suspension for injection Diphtheria (D), tetanus (T), pertussis (acellular component) (Pa),
More informationBoostrix polio. 3. PHARMACEUTICAL FORM Suspension for injection. 4. CLINICAL PARTICULARS
Boostrix polio 1. NAME OF THE MEDICINAL PRODUCT boostrix polio Combined diphtheria, tetanus, acellular pertussis and enhanced inactivated polio vaccine. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION boostrix
More informationRole of Partnerships in Developing Innovative Vaccines: Brazil
Role of Partnerships in Developing Innovative Vaccines: Brazil SAGE Meeting, October 2010 Reinaldo Guimarães, M.D, MSc. Secretary of Science, Technology and Strategic Inputs Ministry of Health of Brazil
More informationINFANRIX IPV PRODUCT INFORMATION
INFANRIX IPV PRODUCT INFORMATION NAME OF THE MEDICINE INFANRIX IPV vaccine is a combined diphtheria, tetanus, acellular pertussis (DTPa) and inactivated poliovirus vaccine. DESCRIPTION INFANRIX IPV vaccine
More informationBenefit Interpretation
Benefit Interpretation Subject: Part B vs. Part D Vaccines Issue Number: BI-039 Applies to: Medicare Advantage Effective Date: May 1, 2017 Attachments: Part B Vaccines Diagnosis Code Limits Table of Contents
More informationChild Health and Disability Prevention (CHDP) Program Code Conversion
Child Health and Disability Prevention (CHDP) Program Code Conversion Health s All s are effective for dates of service on or after July 1, 2017. (Select s for laboratory-only providers with effective
More informationHistory of Vaccines. Stanley A. Plotkin ADVAC HISTORY /21/ :21 AM
History of Vaccines Stanley A. Plotkin ADVAC HISTORY 2014 5/21/2014 11:21 AM 1 Sources of Information on The History of Vaccines: Short: Medium: Long: Chapter 1 of the book Vaccines, By Plotkin and Plotkin
More informationObjectives. Immunity. Childhood Immunization Risk of Non-Vaccinated Children 12/22/2015
Childhood Immunization Risk of Non-Vaccinated Children Bertha P. Rojas, Pharm.D. PGY-1 Pharmacy Resident South Miami Hospital Objectives Understand the definition of herd immunity Identify vaccine-preventable
More informationPREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.
An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation
More informationStudy No.: Title: Rationale: Note: Phase: Study Period: Study Design: Centres: Indication: Treatment: Hib-MenCY F1 Group Hib-MenCY F2 Group
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationThese slides are the property of the presenter. Do not duplicate without express written consent.
Cancer Survivorship Protecting Against Vaccine Preventable Diseases Heidi Loynes BSN, RN Immunization Nurse Educator Michigan Department of health and Human Services (MDHHS) loynesh@michigan.gov Are Vaccine-Preventable
More informationTo demonstrate that DTPa-HBV-IPV/Hib-MenC-TT co-administered with 10Pn, is non-inferior to DTPa-HBV-IPV/Hib coadministered
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationInfanrix TM Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa) vaccine
Infanrix TM Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa) vaccine QUALITATIVE AND QUANTITATIVE COMPOSITION Infanrix TM contains diphtheria toxoid, tetanus toxoid and three purified
More informationVaccine Label Examples
Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can
More informationTable of Contents. 1.0 INFANRIX hexa VACCINE...3
Table of Contents 1.0 INFANRIX hexa VACCINE...3 1.1 What is INFANRIX hexa vaccine?...3 1.2 When will INFANRIX hexa be introduced?...3 1.3 What is the difference between INFANRIX hexa and Pediacel?...3
More information1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector
1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 ) 4. Worldwide Pediatric Vaccines Market Share
More informationVaccine. Specific defenses Immunity. natural. acquired. Live vaccines. Killed Inactivated vaccines. Cellular fraction vaccines
Introduction Vaccine has been a importance medical breakthrough in preventing morbidity and mortality from infectious diseases worldwide. Vaccination has managed to eradicate the deadly and mutilating
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Infanrix hexa, Powder and suspension for suspension for injection. Diphtheria (D), tetanus (T), pertussis (acellular, component)
More informationAdolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
More informationChanges to the National Immunisation Schedule
17 December 2013 Changes to the National Immunisation Schedule PHARMAC is pleased to announce decisions related to the National Immunisation Schedule (NIS) that will take effect from 1 July 2014. This
More informationINFANRIX hexa. Combined Diphtheria-Tetanus-acellular Pertussis (DTPa), Hepatitis B, Poliovirus and Haemophilus influenzae type b vaccine
INFANRIX hexa Product Information 1(12) INFANRIX hexa Combined Diphtheria-Tetanus-acellular Pertussis (DTPa), Hepatitis B, Poliovirus and Haemophilus influenzae type b vaccine DESCRIPTION INFANRIX hexa
More information1. QUALITATIVE AND QUANTITATIVE COMPOSITION
INFANRIX 1. QUALITATIVE AND QUANTITATIVE COMPOSITION contains diphtheria toxoid, tetanus toxoid, and three purified pertussis antigens [pertussis toxoid (PT), filamentous haemagglutinin (FHA) and 69 kilodalton
More informationSUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis-B (rdna) and Haemophilus type b Conjugate Vaccine (Adsorbed) I.P. Injectable, Suspension for injection. 2. QUALITATIVE
More informationONLINE SUPPLEMENTARY APPENDIX. Webtable 1: Survey facilities random sampling
ONLINE SUPPLEMENTARY APPENDIX Webtable 1: Survey facilities random sampling Delhi, also known as the National Capital Territory (NCT) of Delhi, is divided into total 11 districts namely New Delhi, North
More informationACT-HIB powder and solvent for solution for injection Haemophilus influenzae type b Conjugate Vaccine
1 PATIENT INFORMATION LEAFLET ACT-HIB powder and solvent for solution for injection Haemophilus influenzae type b Conjugate Vaccine Read all of this leaflet carefully before your child is vaccinated. Keep
More informationImmunizations are among the most cost effective and widely used public health interventions.
Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean
More informationVaccine Label Examples
Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can
More informationDevelopment of Recombinant Pertussis Vaccines
Development of Recombinant Pertussis Vaccines Wassana Wijagkanalan, PhD BioNet-Asia Co., Ltd, Bangkok, Thailand DCVMN Workshop: Global Registration and Vaccine Shortage 6-10 March 2017, Taipei, Taiwan
More informationINFANRIX HEXA QUALITATIVE AND QUANTITATIVE COMPOSITION PHARMACEUTICAL FORM CLINICAL PARTICULARS. Indications
INFANRIX HEXA Combined diphtheria-tetanus-acellular pertussis, hepatitis B, enhanced inactivated polio vaccine and Haemophilus influenzae type b vaccine QUALITATIVE AND QUANTITATIVE COMPOSITION After reconstitution,
More informationPublic Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.
ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many Medical Policy Title: Immunization Coverage Document: ARB0454:04 Administered by: Public Statement: 1.
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT HEXAVAC suspension for injection in pre-filled syringe Diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis,
More informationTRICARE Retail Vaccination Program Vaccine List - September 2018*
Diphtheria, tetanus and pertussis Diphtheria and tetanus toxoids adsorbed acellular pertussis adsorbed DT DTaP Diphtheria and tetanus toxoids adsorbed Daptacel, Infanrix Tetanus and diphtheria toxoids
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Tetravac, suspension for injection Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine, adsorbed.
More informationPEDIACEL. Intramuscular injection. Suspension for injection. DESCRIPTION
PEDIACEL Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein - Conjugate) Intramuscular
More informationsanofi pasteur 352 Hexaxim New Zealand Data Sheet V2.0 DATA SHEET
DATA SHEET NAME OF THE MEDICINE HEXAXIM DTPa-hepB-IPV-Hib Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rdna), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate
More informationCHILDHOOD VACCINATION
EPI (3) Age of Child How and Where is it given? CHILDHOOD VACCINATION Nicolette du Plessis Block 10 28/02/2012 10 weeks DTaP-IPV/Hib (2) Diphtheria, Tetanus, Acellular pertussis, Inactivated polio vaccine,
More information